References
1. Dunn PM. Dr John Ballantyne (1861-1923): perinatologist extraordinary
of Edinburgh. Archives of disease in childhood. 1993 Jan;68(1 Spec
No):66-7.
2. Hermyt E, Zmarzly N, Jeda-Golonka A, Szczepanek K, Mazurek U, Witek
A. Mirror syndrome: A literature review. [Polish]. Pediatria i
Medycyna Rodzinna. 2019;15(3):246-51.
3. Hobson SR, Wallace EM, Chan YF, Edwards AG, Teoh MWT, Khaw AP-L.
Mirroring preeclampsia: the molecular basis of Ballantyne syndrome. J
Matern Fetal Neonatal Med. 2020 Mar;33(5):768-73.
4. Allarakia S, Khayat HA, Karami MM, Aldakhil AM, Kashi AM, Algain AH,
et al. Characteristics and management of mirror syndrome: a systematic
review (1956-2016). J Perinat Med. 2017 Dec 20;45(9):1013-21.
5. Braun T, Brauer M, Fuchs I, Czernik C, Dudenhausen JW, Henrich W, et
al. Mirror syndrome: a systematic review of fetal associated conditions,
maternal presentation and perinatal outcome. Fetal Diagn Ther.
2010;27(4):191-203.
6. Bellini C, Hennekam RC. Non-immune hydrops fetalis: A short review of
etiology and pathophysiology. American Journal of Medical Genetics Part
A. 2012;158A(3):597-605.
7. Liu H, Zheng Z, Wintour EM. Aquaporins and fetal fluid balance.
Placenta. 2008 Oct;29(10):840-7.
8. Bellini C, Hennekam RC, Fulcheri E, Rutigliani M, Morcaldi G,
Boccardo F, et al. Etiology of nonimmune hydrops fetalis: a systematic
review. Am J Med Genet A. 2009 May;149a(5):844-51.
9. Bond SJ, Harrison MR, Schmidt KG, Silverman NH, Flake AW, Slotnick
RN, et al. Death due to high-output cardiac failure in fetal
sacrococcygeal teratoma. J Pediatr Surg. 1990;25(12):1287-91.
10. Van Mieghem T, Al-Ibrahim A, Deprest J, Lewi L, Langer JC, Baud D,
et al. Minimally invasive therapy for fetal sacrococcygeal teratoma:
case series and systematic review of the literature. Ultrasound Obstet
Gynecol. 2014;43(6):611-9.
11. Hirata G, Aoki S, Sakamaki K, Takahashi T, Hirahara F, Ishikawa H.
Clinical characteristics of mirror syndrome: a comparison of 10 cases of
mirror syndrome with non-mirror syndrome fetal hydrops cases. The
Journal of Maternal-Fetal & Neonatal Medicine. 2016
2016/08/17;29(16):2630-4.
12. Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia:
Pathophysiology, Challenges, and Perspectives. Circ Res. 2019 Mar
29;124(7):1094-112.
13. Huang QT, Wang SS, Zhang M, Huang LP, Tian JW, Yu YH, et al.
Advanced oxidation protein products enhances soluble Fms-like tyrosine
kinase 1 expression in trophoblasts: a possible link between oxidative
stress and preeclampsia. Placenta. 2013 Oct;34(10):949-52.
14. Moffett-King A. Natural killer cells and pregnancy. Nature Reviews
Immunology. 2002 2002/09/01;2(9):656-63.
15. George EM, Cockrell K, Aranay M, Csongradi E, Stec DE, Granger JP.
Induction of heme oxygenase 1 attenuates placental ischemia-induced
hypertension. Hypertension. 2011 May;57(5):941-8.
16. Carbillon L, Oury JF, Guerin JM, Azancot A, Blot P. Clinical
biological features of Ballantyne syndrome and the role of placental
hydrops. Obstet Gynecol Surv. 1997 May;52(5):310-4.
17. Goa S, Mimura K, Kakigano A, Tomimatsu T, Kinugasa-Taniguchi Y, Endo
M, et al. Normalisation of angiogenic imbalance after intra-uterine
transfusion for mirror syndrome caused by parvovirus B19. Fetal Diagn
Ther. 2013;34(3):176-9.
18. Espinoza J, Romero R, Nien JK, Kusanovic JP, Richani K, Gomez R, et
al. A role of the anti-angiogenic factor sVEGFR-1 in the ’mirror
syndrome’ (Ballantyne’s syndrome). J Matern Fetal Neonatal Med. 2006
Oct;19(10):607-13.
19. De Oliveira L, Sass N, Boute T, Moron AF. sFlt-1 and PlGF levels in
a patient with mirror syndrome related to cytomegalovirus infection. Eur
J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):366-7.
20. Hirata G, Aoki S, Sakamaki K, Takahashi T, Hirahara F, Ishikawa H.
Clinical characteristics of mirror syndrome: a comparison of 10 cases of
mirror syndrome with non-mirror syndrome fetal hydrops cases. J Matern
Fetal Neonatal Med. 2016;29(16):2630-4.
21. Grethel EJ, Wagner AJ, Clifton MS, Cortes RA, Farmer DL, Harrison
MR, et al. Fetal intervention for mass lesions and hydrops improves
outcome: a 15-year experience. J Pediatr Surg. 2007 Jan;42(1):117-23.
22. Livingston JC, Malik KM, Crombleholme TM, Lim FY, Sibai BM. Mirror
syndrome: a novel approach to therapy with fetal peritoneal-amniotic
shunt. Obstet Gynecol. 2007 Aug;110(2 Pt 2):540-3.
23. Ishihara Y, Miyata S, Chiba Y, Kawai T. Successful treatment of
extremely severe fetal anemia due to anti-Jra alloimmunization. Fetal
Diagn Ther. 2006;21(3):269-71.